[ Price : $8.95]
FDA issues Regeneron a second complete response letter on its BLA for odronextamab and its use in relapsed/refractory follicular l...[ Price : $8.95]
Allogene Therapeutics modifies its ALPHA3 clinical trial for large B-cell lymphoma following the death of a patient attributed to ...[ Price : $8.95]
FDA approves LENZ Therapeutics Vizz (aceclidine ophthalmic solution) 1.44% for treating presbyopia, a common age-related condition...[ Price : $8.95]
Illumina agrees to pay $9.8 million to settle allegations that it violated the False Claims Act by selling genomic sequencing syst...[ Price : $8.95]
Draeger recalls (Class 1) its SafeStar 90 Plus bidirectional breathing system filter after receiving reports of slow increase of C...[ Price : $8.95]
FDA approves Novo Nordisks Alhemo (concizumab-mtci) as a once-daily preventive treatment for bleeding episodes in patients 12 year...[ Price : $8.95]
FDA says the Innovative Science and Technology Approaches for New Drugs pilot is transitioning into a permanent drug development t...[ Price : $8.95]
Politico reports that despite strong support from FDA commissioner Martin Makary and HHS secretary Robert F. Kennedy, Jr., Preside...